Stock Events

Entheon Biomedical 

€0
1
+€0+0% Friday 07:04

Statistics

Day High
0
Day Low
0
52W High
-
52W Low
-
Volume
0
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31AugConfirmed
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
-0.05
-0.03
-0.01
0.01
Expected EPS
N/A
Actual EPS
0.006

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 1XU1.F. It's not an investment recommendation.

About

Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Show more...
CEO
Mr. Timothy Ko
Employees
3
Country
CA
ISIN
CA29383X1033
WKN
000A2QJBZ

Listings